Write your message
Volume 4, Issue 2 (5-2018)                   IJCA 2018, 4(2): 0-0 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

mahdavynia S. Amiloride vs hydrochlorthiazide therapy in children with nephrotic syndrome, a clinical trial. IJCA 2018; 4 (2)
URL: http://ijca.iums.ac.ir/article-1-58-en.html
iranian
Abstract:   (1127 Views)

Abstract

Aim:

To assess the effectiveness and safety of oral amiloride for the treatment of edema in pediatric patients with idiopathic nephrotic syndrome.

Methods and subjects:

A randomized trial of amiloride vs hydrochlorthiazide was done in 34 patients. The mean age was 4.3±0.7 years old. After a 2 weeks washout of diuretic therapy, nephrotic children with edema were randomized into two groups receiving amiloride vs  hydrochlorthiazide. The effect of diuretics was assessed by the amount of weight reductionand the measurement of urinary fractional excretion of sodium during the first three days of diuretic therapy.

Results:

34 patients were enrolled for this trial (17 patients in amiloride group and 17 patients in hydrochlorthiazide group). The mean weight loss during the first three days of diuretic therapy was 1.3±0.65 kg in amiloride group and 1.19±0.4 kg in hydrochlorthiazide group (PV=0.55). The mean of maximum urinary fractional excretion of sodium during the first three days of diuretic therapy was 2.1±0.65% in amiloride group and 1.8±1% in hydrochlorthiazide group.

Conclusion:

There  was not any difference between amiloride and hydrochlorthiazide medications in reducing weight and increasing urinary fractional excretion of sodium in children with nephrotic syndrome.

     
Type of Study: Original Research |

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | International Journal of Children and Adolescents

Designed & Developed by : Yektaweb